Giordano Natasha bought OGEN

December 11, 2025 · Form 4 insider transaction

Giordano Natasha bought 38,320 shares of Oragenics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
38,320
Price
$0.00
Total value
N/A
Role
SecurityNon-Employee Director Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 11, 2025
Filing dateDecember 15, 2025
Shares owned after38,320
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents an initial equity award upon appointment to the Company's board of directors (the "Board") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025.

View the original Form 4 on SEC EDGAR